Home LiteratureArticle Details
PMID: 10225851 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization.

Clinical and diagnostic laboratory immunology ·Vol. 6 ·No. 3 ·1999-05-00 ·Pages 434-6

Rang CU, Licht TR, Midtvedt T, Conway PL, Chao L, Krogfelt KA, Cohen PS, Molin S

Abstract

The growth physiology of Escherichia coli during colonization of the intestinal tract was studied with four animal models: the streptomycin-treated mouse carrying a reduced microflora, the monoassociated mouse with no other microflora than the introduced strain, the conventionalized streptomycin-treated mouse, and the conventionalized monoassociated mouse harboring a full microflora. A 23S rRNA fluorescent oligonucleotide probe was used for hybridization to whole E. coli cells fixed directly after being taken from the animals, and the respective growth rates of E. coli BJ4 in the four animal models were estimated by correlating the cellular concentrations of ribosomes with the growth rate of the strain. The growth rates thus estimated from the ribosomal content of E. coli BJ4 in vivo did not differ in the streptomycin-treated and the monoassociated mice. After conventionalization there was a slight decrease of the bacterial growth rates in both animal models.

MeSH Terms
Animals Escherichia coli/genetics,growth & development Feces/microbiology Germ-Free Life In Situ Hybridization Intestine, Large/microbiology Male Mice RNA, Bacterial/analysis,genetics RNA, Ribosomal, 23S/analysis,genetics Streptomycin/administration & dosage,pharmacology
Chemicals
RNA, Bacterial RNA, Ribosomal, 23S Streptomycin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Rang C U
Department for General and Marine Microbiology, Göteborg University, Göteborg, Sweden.
Licht T R
Midtvedt T
Conway P L
Chao L
Krogfelt K A
Cohen P S
Molin S
References (19)
19 references, click to expand
  1. Survival and implantation of Escherichia coli in the intestinal tract.
    Infect Immun. 1983 Feb;39(2):686-703 PMID: 6339389
  2. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.
    J Exp Med. 1956 Sep 1;104(3):411-8 PMID: 13357693
  3. Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms.
    Appl Environ Microbiol. 1993 May;59(5):1354-60 PMID: 7685999
  4. Bacterial growth on surfaces: automated image analysis for quantification of growth rate-related parameters.
    Appl Environ Microbiol. 1995 Feb;61(2):741-8 PMID: 16534939
  5. Inhibition of Escherichia coli precursor-16S rRNA processing by mouse intestinal contents.
    Environ Microbiol. 1999 Feb;1(1):23-32 PMID: 11207715
  6. Dependency on medium and temperature of cell size and chemical composition during balanced grown of Salmonella typhimurium.
    J Gen Microbiol. 1958 Dec;19(3):592-606 PMID: 13611202
  7. Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine.
    Infect Immun. 1996 Sep;64(9):3504-11 PMID: 8751891
  8. Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.
    Infect Immun. 1993 Dec;61(12):5029-34 PMID: 8225579
  9. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization.
    Infect Immun. 1996 Sep;64(9):3811-7 PMID: 8751933
  10. Comparative tumor initiating activity on mouse skin of 6-nitrobenzo[a]pyrene, 6-nitrochrysene, 3-nitroperylene, 1-nitropyrene and their parent hydrocarbons.
    Cancer Lett. 1982 Sep;16(3):333-7 PMID: 6295624
  11. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.
    J Hyg (Lond). 1971 Sep;69(3):405-11 PMID: 4999450
  12. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice.
    J Bacteriol. 1995 Oct;177(20):5840-5 PMID: 7592332
  13. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus.
    Infect Immun. 1988 May;56(5):1030-5 PMID: 3281898
  14. Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli.
    J Infect Dis. 1978 May;137(5):624-9 PMID: 351075
  15. Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine.
    Infect Immun. 1990 Sep;58(9):2957-61 PMID: 2201640
  16. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization.
    Infect Immun. 1994 Nov;62(11):5191-4 PMID: 7927805
  17. COMPOSITION, ALTERATION, AND EFFECTS OF THE INTESTINAL FLORA.
    Fed Proc. 1963 Nov-Dec;22:1322-9 PMID: 14071701
  18. Gut flora in normal and disordered states.
    Chemotherapy. 1995;41 Suppl 1:5-15 PMID: 7671648
  19. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine.
    Infect Immun. 1996 Sep;64(9):3497-503 PMID: 8751890
Article Info
Journal
Clinical and diagnostic laboratory immunology
Abbr.
Clin Diagn Lab Immunol
ISSN
1071-412X
Published
1999-05-00
Pages
434-6
Language
English
Region
United States
NLM ID
9421292
PMCID
PMC103738
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com